SymBio Pharmaceuticals Ltd. Sponsored ADR (SYMQY)
Market Closed
30 Jan, 08:00 PM
OTC PINK OTC PINK Primary $
0. 56
0
0%
$
26.38M Market Cap
- P/E Ratio
- Div Yield
1 Volume
- Eps
$ 0.56
Previous Close Want to track SYMQY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
SymBio Pharmaceuticals Ltd. Sponsored ADR (SYMQY) Statistics
Valuation metrics
Market Cap 26.38M
Enterprise value 2.72B
Trailing P/E (ttm) -0.52
Forward P/E -
PEG ratio 0.44
Price/Sales (ttm) 2.53
Price/Book (mrq) -6.81
Enterprise Value/Revenue 2.41
Enterprise Value/EBITDA -0.45
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) 49
Price summary
52-Week low 0.56
52-Week high 0.85
Beta -
50-Day moving average 0.56
200-Day moving average 0.56
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 10 Mar 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -5.33%
Operating margin -5.24%
Operational effectiveness
Return on assets -3.16%
Return on equity -9.37%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 14.81
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -78.95
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 12.8
Total debt (mrq) -
Total Debt/Equity (mrq) -1.43
Current ratio (mrq) 0.75%
Book value per share (mrq) -7.63
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
